{"id":126232,"title":"DSEN Abstract: No evidence identified interventions that decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin 5-hydroxytryptamine 3 receptor (5-HT3) antagonists - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2025-04-10","captureTimestamp":"2025-04-10T11:19:52.205000+00:00","jobId":2,"originalUrl":"https://cihr-irsc.gc.ca/e/52121.html?wbdisable=true","snippet":"DSEN Abstract: No evidence identified interventions that decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin 5-hydroxytryptamine 3 receptor (5-HT3) antagonists - CIHR Skip to main content Skip to \"About this site\" Canada.ca Services…","rawSnapshotUrl":"/api/snapshots/raw/126232","browseUrl":"https://replay.healtharchive.ca/job-2/20250410111952/https://cihr-irsc.gc.ca/e/52121.html?wbdisable=true#ha_snapshot=126232","mimeType":"text/html","statusCode":200}